Rench Wealth Management’s AbbVie ABBV Stock Holding History

Rench Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$215K	Buy	+854	New	+$184K	0.06%	66
2015 Q1	–	Sell	-3,192	Closed	-$209K	–	47
2014 Q4	$209K	Buy	+3,192	New	+$201K	0.18%	48
2014 Q3	–	Sell	-7,644	Closed	-$431K	–	46
2014 Q2	$431K	Buy	7,644 +915	+14%	+$48K	0.38%	31
2014 Q1	$346K	Sell	6,729 -27,872	-81%	-$1.41M	0.33%	34
2013 Q4	$1.83M	Buy	+34,601	New	+$1.7M	1.77%	26

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Rench Wealth Management's ABBV Position: Q2 2026 in Review

Rench Wealth Management opened a new position in AbbVie (ABBV) in Q2 2026: 854 shares worth $215K. The stake represents 0.06% of the portfolio and ranks #66 among its holdings. This is a return to the name: Rench Wealth Management previously reported a position in ABBV as recently as Q4 2014.

Rench Wealth Management first reported a position in ABBV in Q4 2013 and has held it in 5 quarters since. The position peaked at $1.83M in Q4 2013. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Rench Wealth Management held 854 shares of AbbVie worth $215K as of Q2 2026.
AbbVie was a new Rench Wealth Management position in Q2 2026.
AbbVie made up 0.06% of Rench Wealth Management's portfolio in Q2 2026, its #66 holding.
Rench Wealth Management first reported a position in AbbVie in Q4 2013 and has held it in 5 quarters since.
Rench Wealth Management's AbbVie position peaked at $1.83M in Q4 2013.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Rench Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.